Bureau of Justice Assistance

Harold Rogers Prescription Drug Monitoring Program

National Meeting Agenda

Washington, DC Wednesday, September 25, 2013

7:30 am - 8:30 am Check in for all Registrants

8:30 am - 8:45 am Welcome and Overview: Jim Giglio, Director, PDMP Training and Technical Assistance Center

8:45 am - 9:45 am Opening Remarks:

Kristen Mahoney, Deputy Director, Bureau of Justice Assistance

R. Gil Kerlikowske, Director, Office of National Drug Control Policy

Megan O’Donnell, Legislative Director, Office of Congressman Harold ‘Hal’ Rogers

9:45 am - 10:30 am Rx Stat Program: Pooling Data to Impact New York City’s Prescription Problem

Chauncey Parker, Director, NY/NJ HIDTA

Dr. Denise Paone, Director of Research and Surveillance, NYC Department of Health and Mental Hygiene

Ian Hartman-O’Connell, Senior Advisor for Health Policy, NYC Office of the Deputy Mayor for Health & Human Services

10:30 am -11:00 am BREAK

11:00 am – 11:45 am PMIX National Architecture: Advancing Interstate Data Sharing Through Standardization and Innovation

Donald Gabbin, Senior Project Manager, IJIS Institute

Todd Tincher, Project Manager, Appriss Inc.

Don Vogt, Program Manager, OK Bureau of Narcotics

11:45 am – 1:00 pm LUNCH BREAK

1:00 pm - 1:45 pm National Governors Association (NGA) Rx Policy Academy: Leaders Convening to Impact Statewide Prescription Abuse

Thomas MacLellan, Director, NGA Homeland Security & Public Safety Division

Jeffrey McLeod, Senior Policy Analyst, NGA Homeland Security & Public Safety Division

1:45 pm - 2:30 pm PDMP Center Of Excellence: Improving PDMPs Through Research

John Eadie, Director, PDMP Center of Excellence

Dr. Peter Kreiner, Principal Investigator, PDMP Center of Excellence

2:30 pm – 3:00 pm BREAK

3:00 pm – 4:00 pm Association of State and Territorial Health Officials (ASTHO) Project: Connecting Public Health and PDMPs

Grant Carrow, Consultant (moderator), PDMP Center of Excellence

Dr. Paul Jarris, Executive Director, ASTHO

Andrew Holt, Administrator, TN Controlled Substance Monitoring Database

Chad Garner, Director of OARRS, OH Board of Pharmacy

4:00 pm – 4:30 pm NarxCheck: A Tool to Provide “Credit like Reports” Based on PDMP Data - Marty Allain, NarxCheck Senior Manager, NABP

Bureau of Justice Assistance

Harold Rogers Prescription Drug Monitoring Program

National Meeting Agenda

Washington, DC Thursday, September 26, 2013

8:00 am - 8:30 am Check in

8:30 am - 9:15 am Bureau of Justice Assistance: A Look into the Future of PDMPs – Christopher Traver, Senior Policy Advisor, Bureau of Justice Assistance

9:15 am - 9:45 am Implementing PDMP Best Practices: 3 PDMPs’ Innovative Approaches to Improvement

Dave Hopkins, KASPER Project Manager, KY Cabinet for Health and Family Services

Andrew Holt, Administrator, TN Controlled Substance Monitoring Database

Mike Small, CURES Program Manager, CA Department of Justice

9:45 am - 10:00 am BREAK

10:00 am - 10:45 am Maryland PDMP: A Unique Approach to Implementing a PDMP with a Health Information Exchange - Michael Baier, PDMP Coordinator, MD Alcohol and Drug Abuse Administration

10:45 am - 11:30 am Nebraska Health Information Initiative (NeHII): Operating a PDMP through a Health Information Exchange - Deb Bass, Chief Executive Officer, NeHII

11:30 am - 12:15 pm Drug Enforcement Administration: Inside Diversion Control – Cathy Gallagher, Liaison and Policy Section Chief, DEA Office of Diversion Control

12:15 pm – 12:45 pm Meet with BJA Policy Advisor: State BJA PDMP Grantees

12:15 pm – 1:45 pm LUNCH BREAK

1:45 pm - 2:30 pm Substance Abuse and Mental Health Services Administration (SAMHSA): Prevention Works – Dr. Deborah Galvin, Public Health Analyst, SAMHSA

2:30 pm – 3:00 pm Harold Rogers Enhancement Projects: 2 States’ Approaches to Improving a PDMP

John Lipovsky, PDMP Coordinator, ME Office of Substance Abuse and Mental Health Services

Erika Marshall, Program Outreach Director, FL Prescription Drug Monitoring Program

3:00 pm - 3:30 pm BREAK

3:30 pm – 4:15 pm Prescription Behavior Surveillance System Project: The Power of PDMP Data –

Dr. Len Paulozzi, Medical Epidemiologist, Centers for Disease Control and Prevention

Dr. Douglas Throckmorton, Deputy Director for Regulatory Programs, Food and Drug Administration

4:15 pm - 5:00 pm National Alliance for Model State Drug Laws (NAMSDL): Legal Analysis on Emerging PDMP Issues – Sherry Green, Chief Executive Officer, NAMSDL

Telephone: (781) 609-7741 | Fax: (888) 705-8053 | Email: info@pdmpassist.org | Website: www.pdmpassist.org

Bureau of Justice Assistance

Harold Rogers Prescription Drug Monitoring Program

National Meeting Agenda

Washington, DC Friday, September 27, 2013

8:15 am - 8:30 am Check in

8:30 am – 9:15 am Oregon PDMP National Institutes of Health Study: Use of PDMPs in Clinical Setting

Jessica Irvine, Project Manager, Acumentra Health

Dr. Richard A. Deyo, Professor of Family Medicine, OR Health and Science University

9:15 am – 9:45 am Harold Rogers Enhancement Projects: 2 States’ Approaches to Improving a PDMP

Adele Audet, Assistant Director, MA Drug Control Program

Chris Baumgartner, PMP Director, WA State Department of Health

9:45 am – 10:15 am HIE Pilots/Grants: Connecting PDMPs to Electronic Health Records

Jennifer Frazier, Health Policy Analyst, Office of the National Coordinator for Health IT

Jinhee Lee, Public Health Advisor, SAMHSA

10:15 am – 10:45 am BREAK / HOTEL CHECKOUT

10:45 am - 11:15 am Electronic Health Record Pilots: “Breaking New Ground” – Experiences of 2 PDMPs

Gregory Pachmayr, INSPECT Director, IN Board of Pharmacy

Craig Berberet, PMP Data Manager, IL Department of Human Services

11:15 am - 11:45 am Closing Remarks: Michael Botticelli, Deputy Director, Office of National Drug Control Policy

11:45 am - 12:15 pm Closing Remarks: Jim Giglio, Director, PDMP Training and Technical Assistance Center

This project is supported by Grant No. 2011-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau

of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice

Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, and the Office

for Victims of Crime. Points of view or opinions in this document are those of the author and do not represent the

official position or policies of the U.S. Department of Justice.

Brandeis University

The Heller School for

Social Policy and Management